A large study of families suggests that a child’s overall attention-deficit hyperactivity disorder traits are primarily ...

Opus is developing gene therapies for inherited retinal diseases, including OPGx-BEST1 for Best disease and OPGx-LCA5 for ...

Ambry Genetics, a wholly owned subsidiary of Tempus AI (NASDAQ:TEM), has introduced GenomeNext and GenomeReveal, a new whole ...

Seed Junky Genetics, one of the cannabis industry's most influential genetics companies, today announced a significant ...

Scientists accidentally discovered a microscopic organism with a genetic code that breaks a rule researchers thought was ...

If you had looked at Myriad Genetics in October 2025, seen bullish talk about genomics, AI and precision medicine, then ...

HS is far more common than most clinicians realize, and its origins are multifactorial. Understanding genetic, mechanical, ...

Myriad Genetics, SOPHiA GENETICS and AstraZeneca are collaborating to advance Myriad’s prostate cancer genomic instability ...

This study presents RovHer, a heritability-optimized scoring method for estimating the functional impact of rare variants, which is applied to the UK Biobank to demonstrate its ability to enrich for ...

Susan Dymecki, the George Fabyan Professor of Genetics in the Field of Comparative Pathology in the Blavatnik Institute at Harvard Medical School, has been named the next chair of the HMS Department ...

Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing ...

James Peterson discusses driving the century-old berry grower forward by pairing high-tech quality control and proprietary ...